DRAP REGISTERED MEDICAL DEVICE
Maglumi Homocysteine (CLIA) is registered with DRAP under number MDIR-0009213 as a Class C (moderate to high risk) medical device, imported. The listed holder is Snibe Diagnostic Pakistan (SMC-Private) Limited. It is listed as valid until 29 Apr 2030.
Screening result
MDIR-0009213
DRAP registered Class B/C/D list, 28 Aug 2025
That list covers manually issued licences only. Ask for a copy of the establishment licence.
| Device | Maglumi Homocysteine (CLIA) |
|---|---|
| Class | C |
| Listed holder | Snibe Diagnostic Pakistan (SMC-Private) Limited |
| Holder address | No.A-107, 1st Floor, Fortune Towers, PECHS, Shahra-e-Faisal, Karachi. |
| Manufacturing site | M/s Shenzhen New Industries Biomedical Engineering Co. Ltd. (SNIBE) No. 23, Jinxiu Est Road, Pingshan District, Shenzen, China. |
| Issued | 30 Apr 2025 |
| Renewal date | 29 Apr 2030 |
Specifications
No supplier specifications yet.
Supplier of this device? Add specifications (free during launch)
Sign in or create a free account to add specifications.
Screened 5 Oct 2026, 04:46 (Pakistan time). A screening aid, not an official DRAP verification.
More devices from this holder
Other DRAP registrations and enlistments listed for the same company.
| MDIR-0009206 | Maglumi a2-Plasmininhibitor-pla smin Complex (CLIA) | Class C |
| MDIR-0009207 | Maglumi thrombin-antithrombin III Complex (CLIA) | Class C |
| MDIR-0009208 | Maglumi Tissue Plasminogen activator-plasminogen activator inhibitor complex (CLIA) | Class C |
| MDIR-0009209 | Maglumi Chlamydia pneumoniae IgM (CLIA) | Class C |
| MDIR-0009210 | Maglumi Thrombomodulin (CLIA) | Class C |
| MDIR-0009211 | Maglumi Mycoplasma pneumoniae IgM (CLIA) | Class C |
| MDIR-0009212 | Maglumi Mycoplasma pneumoniae IgG (CLIA) | Class C |
| MDIR-0009214 | Maglumi hs-CRP (CLIA) | Class C |
| MDIR-0009215 | Maglumi Chlamydia Pneumoniae IgG (CLIA) | Class C |
| MDIR-0009216 | Maglumi HSV-2 IgM (CLIA) | Class C |
| MDIR-0009217 | Maglumi HSV-1 IgM (CLIA) | Class C |
| MDIR-0009218 | Bioassays - Hemoglobin A1c Controls | Class C |
Corrections
Is something on this page wrong? Report a correction
Corrections are checked against the evidence before anything changes on this page.
Screen another number
Source: DRAP's published provisional lists. A screening aid, not an official DRAP verification; confirm with DRAP and the supplier's original documents.